MeiraGTx gene therapy stabilizes weight in mouse study of genetic obesity
MGTX•MeiraGTx said a single injection of its AAV-BDNF gene therapy stabilized weight and normalized glucose tolerance in mice with BDNF deficiency. The company will present the preclinical results at ObesityWeek on Nov. 16, 2026.
1. Mouse study results
MeiraGTx said a single injection of AAV-BDNF stabilized weight and normalized glucose tolerance in mice with BDNF deficiency. Treatment also reduced aggressive behaviors without impairing social interactions, and blood tests showed a favorable safety profile.




